PetMeds (PETS) Stock Price
$3.09 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
8 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on PetMeds, AI stock picks, stock alerts and much more.
PETS AI Stock Analysis
AI stock analysis for PETS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like PetMeds (PETS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
PetMeds (PETS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of PetMeds (PETS), currently trading at $3.09, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About PETS
-
PetMed Express, Inc.
-
Symbol
PETS
-
Market
NASDAQ
-
Industry
Medical - Pharmaceuticals
-
Market Cap
63.8M
Similar Stocks
 |
Walgreens WBA |
$10.89 0.8% |
3 |
News
PETS Alternative Data
Web Traffic
PetMeds receives an estimated 1.4M monthly visitors to 1800petmeds.com.
-
Web Traffic
1355215
-
Change from Previous Month
53.9%
-
3 Month Change
37.6%
-
YoY Change
37.6%
News Mentions
PetMeds was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
PetMeds has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
Facebook Engagement
PetMeds has engaged 18,107 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
18107
-
Daily Change
12.8%
-
1 Month Change
95.4%
-
3 Month Change
39.8%
-
YoY Change
39.8%
Instagram Followers
PetMeds has 63,535 Instagram Followers on its main Instagram account, up by 0.2% over the last month.
-
Instagram Followers
63535
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Youtube Subscribers
PetMeds has 2,220 subscribers on its main Youtube channel, up by 0.5% over the last month.
-
Youtube Subscribers
2220
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
0.5%
-
YoY Change
0.5%
LinkedIn Followers
9,303 are following PetMeds on LinkedIn, up by 18.7% over the last month.
-
LinkedIn Followers
9303
-
Daily Change
0%
-
1 Month Change
18.7%
-
3 Month Change
41%
Job Postings
PetMeds has an estimated 1 open job postings, which is down -85.7% over the last month.
-
Job Postings
1
-
Daily Change
0%
-
1 Month Change
85.7%
-
3 Month Change
85.7%
-
YoY Change
85.7%
App Downloads
-
App Downloads
1002
-
Daily Change
0%
-
1 Month Change
50000%
-
3 Month Change
50000%
-
YoY Change
50000%
TikTok Followers
PetMeds has 10,100 Followers on its main TikTok account.
-
TikTok Followers
10100
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, PetMeds has 228 employees.
-
LinkedIn Employees
228
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
2.2%
-
YoY Change
2.2%
Business Outlook
According to employee reviews, the business outlook among employees at PetMeds is 65 out of 100 (bullish).
-
Business Outlook
65
-
Change from Previous Month
13.3%
-
3 Month Change
0%
-
YoY Change
0%
Twitter Followers
PetMeds has 16,324 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
16324
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
PETS Financials
PETS Key Metrics
-
Total Revenue
$53M
-
Net Income
-$707K
-
Earnings per Share
-$0.0343
-
Free cash flow
-$1.9M
-
EBITDA
$1.1M
-
EBITDA Ratio
0.0214404
-
Total Assets
$144.8M
PETS 2-year Revenue & Income
PETS 2-year Free Cash Flow
PETS Technicals
PETS SMA
PETS RSI
FAQ
What's the current price of PetMeds (PETS) Stock?
The price of an PetMeds (PETS) share is $3.09.
What's the market cap of PetMeds?
The current market cap of PetMeds is 63.8M.
Should I buy or sell PETS?
PetMeds shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, PetMeds is better viewed as a hold or accumulate position while waiting for further developments.
Is PetMeds a good investment?
The current analysis of PetMeds' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in PetMeds' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy PetMeds (PETS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for PetMeds stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to PetMeds (PETS) that investors often compare it to?
PetMeds (PETS) is often compared to similar stocks such as Walgreens.
What is the forecast for PetMeds' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast PetMeds' stock price to be around $3.23 in 2026. Starting from the current price of $3.09, this represents a 4.4% change in price, indicating a neutral outlook for the stock.
How to buy PetMeds (PETS) Stock?
PetMeds stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy PetMeds shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.